🔎 Trials Near Me

መነሻ › በርኪት ሊምፎማ › ካንሳስ

በካንሳስ ለበርኪት ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለበርኪት ሊምፎማ የሚደረጉ 6 ጥናቶች በካንሳስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በካንሳስ ውስጥ ያሉ ከተሞች

Official study text (English)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Hospital-Westwood Cancer Center, Westwood
  • Cancer Center of Kansas - Wichita, Wichita
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Hospital-Westwood Cancer Center, Westwood
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03739814

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Wesley Medical Center, Wichita
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Children's Mercy Hospital, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ7 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05082519

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

  • University of Kansas Clinical Research Center, Fairway
  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT07069699

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

  • University of Kansas Cancer Center, Westwood
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሜይ 2026 · NCT06879340

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።